Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruby Yun-Ju Huang

Showing results (51-60 of 84) with videos related to

Pageof 9
Sort By:
Cancers|January 23, 2020
Cytoskeletal Proteins in Cancer and Intracellular Stress: A Therapeutic PerspectiveMei Shan Ong, Shuo Deng, Clarissa Esmeralda Halim, et al.
Breast Cancer Research : BCR|October 15, 2025
Carcinomas exhibiting epithelial-mesenchymal transition manifest an M2 macrophage-enriched tumor immune microenvironmentHuang-Chun Lien, Yu-Chia Li, Ruby Yun-Ju Huang, et al.
ACS Pharmacology & Translational Science|December 21, 2020
Pharmacological Inhibition of BAD Ser99 Phosphorylation Enhances the Efficacy of Cisplatin in Ovarian Cancer by Inhibition of Cancer Stem Cell-like BehaviorYanxin Wang, Yi-Shiou Chiou, Qing-Yun Chong, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|November 23, 2012
Screening therapeutic EMT blocking agents in a three-dimensional microenvironmentAmir R Aref, Ruby Yun-Ju Huang, Weimiao Yu, et al.
Scientific Reports|February 19, 2016
GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modificationVin Yee Chung, Tuan Zea Tan, Ming Tan, et al.
Cancer Letters|September 10, 2016
A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targetsDongyu Jia, Zhenqiu Liu, Nan Deng, et al.
Cancers|January 8, 2023
The CAM Model-Q&A with ExpertsDagmar Fischer, Georg Fluegen, Paul Garcia, et al.
The Analyst|August 5, 2014
A spatiotemporally defined in vitro microenvironment for controllable signal delivery and drug screeningChing-Te Kuo, Hao-Kai Liu, Guan-Syuan Huang, et al.
International Journal of Cancer|January 11, 2023
Immune-Hot tumor features associated with recurrence in early-stage ovarian clear cell carcinomaRuby Yun-Ju Huang, Kuan-Ju Huang, Ko-Chen Chen, et al.
Lab on a Chip|July 2, 2020
Functional reservoir microcapsules generated via microfluidic fabrication for long-term cardiovascular therapeuticsNgoc-Duy Dinh, Marek Kukumberg, Anh-Tuan Nguyen, et al.
Pageof 9

Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
Cancers|January 23, 2020
Cytoskeletal Proteins in Cancer and Intracellular Stress: A Therapeutic PerspectiveMei Shan Ong, Shuo Deng, Clarissa Esmeralda Halim, et al.
Breast Cancer Research : BCR|October 15, 2025
Carcinomas exhibiting epithelial-mesenchymal transition manifest an M2 macrophage-enriched tumor immune microenvironmentHuang-Chun Lien, Yu-Chia Li, Ruby Yun-Ju Huang, et al.
ACS Pharmacology & Translational Science|December 21, 2020
Pharmacological Inhibition of BAD Ser99 Phosphorylation Enhances the Efficacy of Cisplatin in Ovarian Cancer by Inhibition of Cancer Stem Cell-like BehaviorYanxin Wang, Yi-Shiou Chiou, Qing-Yun Chong, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|November 23, 2012
Screening therapeutic EMT blocking agents in a three-dimensional microenvironmentAmir R Aref, Ruby Yun-Ju Huang, Weimiao Yu, et al.
Scientific Reports|February 19, 2016
GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modificationVin Yee Chung, Tuan Zea Tan, Ming Tan, et al.
Cancer Letters|September 10, 2016
A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targetsDongyu Jia, Zhenqiu Liu, Nan Deng, et al.
Cancers|January 8, 2023
The CAM Model-Q&A with ExpertsDagmar Fischer, Georg Fluegen, Paul Garcia, et al.
The Analyst|August 5, 2014
A spatiotemporally defined in vitro microenvironment for controllable signal delivery and drug screeningChing-Te Kuo, Hao-Kai Liu, Guan-Syuan Huang, et al.
International Journal of Cancer|January 11, 2023
Immune-Hot tumor features associated with recurrence in early-stage ovarian clear cell carcinomaRuby Yun-Ju Huang, Kuan-Ju Huang, Ko-Chen Chen, et al.
Lab on a Chip|July 2, 2020
Functional reservoir microcapsules generated via microfluidic fabrication for long-term cardiovascular therapeuticsNgoc-Duy Dinh, Marek Kukumberg, Anh-Tuan Nguyen, et al.
Pageof 9